1. Home
  2. GDC vs ENSC Comparison

GDC vs ENSC Comparison

Compare GDC & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GD Culture Group Limited

GDC

GD Culture Group Limited

HOLD

Current Price

$1.50

Market Cap

6.5M

Sector

Industrials

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.44

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDC
ENSC
Founded
2015
2003
Country
United States
United States
Employees
5
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
GDC
ENSC
Price
$1.50
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6M
18.1M
Earning Date
04-10-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.24
EPS
N/A
N/A
Revenue
N/A
$5,066,650.00
Revenue This Year
N/A
$55.01
Revenue Next Year
N/A
$1,033.97
P/E Ratio
$7.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.23
52 Week High
$9.92
$2.75

Technical Indicators

Market Signals
Indicator
GDC
ENSC
Relative Strength Index (RSI) 46.73 63.64
Support Level $1.35 $0.34
Resistance Level $2.07 $0.61
Average True Range (ATR) 0.41 0.03
MACD -0.05 0.00
Stochastic Oscillator 9.61 99.48

Price Performance

Historical Comparison
GDC
ENSC

About GDC GD Culture Group Limited

GD Culture Group Ltd operates and manages its business as a single segment and has one operating and reportable segment, the Virtual Content Production. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: